Kinder Jeremy M, Jiang Tony T, Ertelt James M, Xin Lijun, Strong Beverly S, Shaaban Aimen F, Way Sing Sing
a Division of Infectious Diseases and Perinatal Institute, Cincinnati Children's Hospital, Cincinnati , OH , USA.
b Center for Fetal Cellular and Molecular Therapy, Cincinnati Children's Hospital , Cincinnati , OH , USA.
Chimerism. 2015 Apr 3;6(1-2):8-20. doi: 10.1080/19381956.2015.1107253. Epub 2015 Oct 30.
Compulsory exposure to genetically foreign maternal tissue imprints in offspring sustained tolerance to noninherited maternal antigens (NIMA). Immunological tolerance to NIMA was first described by Dr. Ray D. Owen for women genetically negative for erythrocyte rhesus (Rh) antigen with reduced sensitization from developmental Rh exposure by their mothers. Extending this analysis to HLA haplotypes has uncovered the exciting potential for therapeutically exploiting NIMA-specific tolerance naturally engrained in mammalian reproduction for improved clinical outcomes after allogeneic transplantation. Herein, we summarize emerging scientific concepts stemming from tolerance to NIMA that includes postnatal maintenance of microchimeric maternal origin cells in offspring, expanded accumulation of immune suppressive regulatory T cells with NIMA-specificity, along with teleological benefits and immunological consequences of NIMA-specific tolerance conserved across mammalian species.
强制接触基因上异源的母体组织会使后代对非遗传母体抗原(NIMA)产生持续耐受性。对NIMA的免疫耐受性最早由雷·D·欧文博士描述,他研究了红细胞恒河猴(Rh)抗原基因阴性的女性,这些女性因母亲孕期接触Rh而致敏性降低。将这种分析扩展到人类白细胞抗原(HLA)单倍型,揭示了一个令人兴奋的潜在应用方向,即利用哺乳动物生殖过程中自然存在的NIMA特异性耐受性,改善同种异体移植后的临床效果。在此,我们总结了源于对NIMA耐受性的新兴科学概念,包括后代中微嵌合母体来源细胞的产后维持、具有NIMA特异性的免疫抑制调节性T细胞的积累增加,以及跨哺乳动物物种保守的NIMA特异性耐受性的目的论益处和免疫后果。